Primer: Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436 CH) - Sep 2025
Dominant Market Position Solidified by State Protection: Zhangzhou Pientzehuang's core product, the Pientzehuang series, is a Class-1 protected...
31 Views
CSI 100 Index Earning Revision (Nov): CHINA VANKE, PING AN INSURANCE, BOE, TCL
We analyzed CSI 100's consensus for Nov 2025 and highlighted changes of EPS in CHINA VANKE (000002 CH), PING AN INSURANCE (601318 CH), BOE...
268 Views
Jiangsu Hengrui Pharma (600276 CH): Index Inclusion Post H-Share Listing
Jiangsu Hengrui has filed an application proof for an HKEX listing. Reports indicate a US$2bn raise. There will be no index Fast Entry but...
1.2k Views
Quiddity SSE50/180 Dec 24 Results: All SSE 50 ADDs in the LONGs Basket; Positive Start; More to Come
All five SSE 50 ADDs are in our previous LONGs basket. Since 5th Nov, the LONGs have outperformed the index by 2.7% which was a better return than...
671 Views
SSE50/SSE180 Index Rebalance: Couple of Surprises; Seres Group's Multiple Inclusions; US$3.2bn Trade
5/18 changes for the SSE50/180 in Dec. Seres Group is an add to both indices and the CSI300, so plenty to buy there. Couple of other surprises. The...
713 Views